A detailed history of Rathbones Group PLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Rathbones Group PLC holds 101,597 shares of BDX stock, worth $23.1 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
101,597
Previous 98,546 3.1%
Holding current value
$23.1 Million
Previous $23 Million 6.36%
% of portfolio
0.13%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$221.47 - $242.41 $675,704 - $739,592
3,051 Added 3.1%
101,597 $24.5 Million
Q2 2024

Aug 09, 2024

SELL
$225.07 - $246.17 $4.49 Million - $4.91 Million
-19,930 Reduced 16.82%
98,546 $23 Million
Q1 2024

May 14, 2024

SELL
$233.45 - $247.73 $3.55 Million - $3.77 Million
-15,223 Reduced 11.39%
118,476 $29.3 Million
Q4 2023

Feb 13, 2024

BUY
$232.24 - $267.23 $5.31 Million - $6.11 Million
22,849 Added 20.61%
133,699 $32.6 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $1.42 Million - $1.58 Million
-5,554 Reduced 4.77%
110,850 $28.7 Million
Q2 2023

Aug 04, 2023

SELL
$238.39 - $265.32 $2.19 Million - $2.44 Million
-9,200 Reduced 7.32%
116,404 $30.7 Million
Q1 2023

May 12, 2023

BUY
$229.71 - $259.35 $981,780 - $1.11 Million
4,274 Added 3.52%
125,604 $31.1 Million
Q4 2022

Feb 14, 2023

SELL
$218.29 - $256.91 $261,948 - $308,292
-1,200 Reduced 0.98%
121,330 $30.9 Million
Q3 2022

Nov 03, 2022

BUY
$51.03 - $264.23 $223,460 - $1.16 Million
4,379 Added 3.71%
122,530 $27.3 Million
Q2 2022

Aug 12, 2022

SELL
$234.74 - $275.42 $84,975 - $99,702
-362 Reduced 0.31%
118,151 $29.1 Million
Q1 2022

May 11, 2022

SELL
$243.64 - $270.48 $5.52 Million - $6.13 Million
-22,674 Reduced 16.06%
118,513 $31.5 Million
Q4 2021

Feb 10, 2022

SELL
$230.08 - $250.94 $8.51 Million - $9.28 Million
-36,981 Reduced 20.76%
141,187 $35.5 Million
Q3 2021

Nov 04, 2021

SELL
$232.72 - $256.47 $86,339 - $95,150
-371 Reduced 0.21%
178,168 $43.8 Million
Q2 2021

Jul 30, 2021

BUY
$232.65 - $254.58 $5.03 Million - $5.5 Million
21,605 Added 13.77%
178,539 $43.4 Million
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $4.35 Million - $4.81 Million
18,744 Added 13.56%
156,934 $38.2 Million
Q4 2020

Feb 11, 2021

BUY
$221.92 - $245.94 $1.72 Million - $1.91 Million
7,746 Added 5.94%
138,190 $34.6 Million
Q3 2020

Nov 13, 2020

SELL
$215.77 - $276.76 $33.6 Million - $43 Million
-155,548 Reduced 54.39%
130,444 $30.4 Million
Q2 2020

Aug 07, 2020

BUY
$219.9 - $263.41 $19.7 Million - $23.6 Million
89,534 Added 45.57%
285,992 $68.4 Million
Q1 2020

May 04, 2020

BUY
$195.69 - $279.01 $228,565 - $325,883
1,168 Added 0.6%
196,458 $45.1 Million
Q4 2019

Feb 11, 2020

SELL
$236.45 - $266.82 $1.54 Million - $1.74 Million
-6,526 Reduced 3.23%
195,290 $53.1 Million
Q3 2019

Nov 13, 2019

BUY
$230.58 - $256.08 $1.07 Million - $1.18 Million
4,626 Added 2.35%
201,816 $51.1 Million
Q2 2019

Aug 12, 2019

BUY
$217.4 - $246.08 $350,883 - $397,173
1,614 Added 0.83%
197,190 $49.7 Million
Q1 2019

May 09, 2019

SELL
$206.05 - $248.17 $1.63 Million - $1.96 Million
-7,913 Reduced 3.89%
195,576 $48.8 Million
Q4 2018

Feb 12, 2019

BUY
$204.73 - $257.93 $64,899 - $81,763
317 Added 0.16%
203,489 $45.9 Million
Q3 2018

Oct 12, 2018

BUY
$233.07 - $256.0 $148,698 - $163,328
638 Added 0.32%
203,172 $53 Million
Q2 2018

Jul 16, 2018

BUY
$208.1 - $233.85 $3.36 Million - $3.78 Million
16,146 Added 8.66%
202,534 $48.5 Million
Q1 2018

Apr 06, 2018

BUY
$205.46 - $240.27 $24.9 Million - $29.1 Million
121,162 Added 185.76%
186,388 $40.4 Million
Q4 2017

Jan 24, 2018

BUY
$189.0 - $222.64 $149,688 - $176,330
792 Added 1.23%
65,226 $14 Million
Q3 2017

Oct 24, 2017

BUY
$186.89 - $198.9 $12 Million - $12.8 Million
64,434
64,434 $12.6 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.